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to innovative nanomaterials in medi-
cal and consumer products is accom-
panied by specific issues regarding the
safety and life cycle of nanomaterials in
the environment and, more particularly, in
the human body. Materials with one or
several dimensions smaller than 100 nm
have increasing complex and dynamic in-
teractions with both environmental and
biological systems.1,2 An overall objective
is to correlate the synthetic identity of
nanoparticles to their behavior and trans-
formations in living organisms, and their
physicochemical properties with biological
functions.38 Understanding the (bio)trans-
formations of nanomaterials over their
entire life cycle is thus a pivotal challenge
of nanoscience and a critical issue for socie-
tal acceptability.9
While most nanotoxicology studies focus
on the biochemical effects caused by
particles,10 the information on the transfor-
mations inflicted by the biological environ-
ment to the nanoparticles are still scarce
or limited to a short time frame after
administration.1115 We recently proposed
that the nanoparticles physical properties
evolve over their life cycle (e.g., their mag-
netic properties) and the ability to probe the
evolution would allow for the identification
of the length of time (i.e., age) of nano-
particles in the organism.16,17 Nanoparticles
may undergo morphological and structural
transformations such as degradation, disso-
ciation, dissolution, agglomeration. Here,
we propose to use a combination of quali-
tative and quantitative analytical techni-
ques to study and monitor the long-term
fate and biodegradation of gold/iron oxide
nanoheterostructures (NHs) over one year
after parenteral administration in mice.
Gold and iron oxide nanoparticles are two
of the most studied inorganic nanomate-
rials due to their unique optical and mag-
netic properties.18,19 These NHs may be
used as theranostic agents with imaging
and therapeutic applications, such as for
MRI imaging and hyperthermia.20,21 How-
ever, the safety of nanoparticles, as well
as their efficacy, depends on how they
transform in the organism.22 While gold
Abstract: Safe implementation of nanotechnology and nanomedicine requires an in-depth understanding of the life cycle of nanoparticles in 
the body. Here, we investigate the long-term fate of gold/iron oxide heterostructures after intravenous injection in mice. We show these hetero-
structures degrade in vivo and that the magnetic and optical properties change during the degradation process. These particles eventually 
eliminate from the body. The comparison of two different coating shells for heterostructures, amphiphilic polymer or polyethylene glycol, reveals 
the long lasting impact of initial surface properties on the nanocrystal degradability and on the kinetics of elimination of magnetic iron and gold 
from liver and spleen. Modulation of nanoparticles reactivity to the biological environment by the choice of materials and surface 
functionalization may provide new directions in the design of multifunctional nanomedicines with predictable fate.
nanoparticles are considered as a relatively bioinert
material, concerns are raised by their persistent accu-
mulation in the body.2326 Moreover, gold particles
become catalytic and highly reactive as their size is
decreased to a few nanometers and interestingly some
biological effects have been reported on small size
gold particles.27,28 Therefore, themorphological evolu-
tion of persistent gold particles in the body should
be evaluated and the size-dependent elimination/
excretion resulting from potential in vivo degradation
have to be elucidated.23,29 In contrast to gold particles,
iron oxide may benefit from iron metabolism and can
be processed and assimilated by the organism.30,31 We
have shown before that the superparamagnetic prop-
erties of intravenously administered iron oxide nano-
spheres and nanocubes were degraded over a few
months after accumulation in the liver and the spleen,
while the endogenous form of iron stored in ferritin
protein was increased.17,32 The loss of magnetic prop-
erties of the initial nanomagnets was correlated to the
degradation of single iron oxide nanocrystal by acidic
medium such as the lysosome.32,33 Remarkably, the
coating of iron oxide nanoparticles drastically affects
the kinetics of particle degradation in situ in acidic
medium.16,34 For example, the edge of nanocubes
dissolves when their surface is coated by a less dense
polymer, but the remaining parts of the cube retain
their original crystalline structure.32 However, it is not
clear if the same mechanisms of local degradation and
protective effect of the coatingmay be relevant in vivo.
Here, we further testedwhether coating of NHswith an
amphiphilic polymer and polyethylene glycol influ-
enced the degradation fate over 6 months following
injection.
RESULTS AND DISCUSSION
The heterostructures used in this study consisted of
a gold monocrystalline core of 4.7 ( 1.0 nm coated
with magnetite or maghemite nanocrystals (Figure 1A)
with a mean overall size of 13.4 ( 3.2 nm. They were
synthesized by thermal decompositionmethod follow-
ing the procedure of Sun.35 This nonhydrolytic syn-
thesis consists in the in situ nucleation of gold seeds on
which the iron oxide nanocrystals can selectively grow.
High-Resolution TEM (HRTEM) observations reveal that
gold and iron oxide structures are mostly found in
cube-on-cube epitaxy. This epitaxial growth is energe-
tically favorable because the lattice parameter of the
inverse spinel structure of magnetite or maghemite
(0.840 and 0.835 nm) is almost two times larger than a
single FCC gold structure (0.408 nm). This is illustrated
in Figure 1B showing a heterostructure oriented along
the [001] zone axis. The fast Fourier transformations
(FFT) calculated on the iron oxide structure and on the
superposed gold/iron oxide structures are identical,
because the [004] and [440] reflections of iron oxide are
superposedwith the [002] and [220] reflections of gold.
We note that NHs with the vacancy-ordered maghe-
mite structure (tetragonal unit cell with the P41212
space group) were also observed.3638
As synthesized hydrophobic surfactant-coated NHs
(surfactants: oleic acid, oleylamine and 1,2-hexa-
decanediol) were transferred to water by two distinct
procedures. The first one is based on the intercalation
of an amphiphilic polymer, namely, poly(maleic anhy-
dride alt-1-octadecene) of 3050 kDa, on top of the
surfactant coated NHs, forming a micelle-like coat-
ing.39,40 Colloidal stability and negative charges of
the particles were confirmed in water by dynamic light
scattering (DLS) and electrophoresis (Supporting In-
formation Figure S1). Alternatively, in a second ap-
proach we used a catechol-derived polyethylene
glycol ligand (gallol-PEGOH, 3 kDa) adapted by a
previously developed protocol,41 to anchor the iron
oxide surface with the gallic acid groups by replacing
the surfactant molecules present on the as synthesized
NHs. Polyethylene glycol molecules stabilize the het-
erostructures by steric hindrance (Supporting Informa-
tion Figure S2).42 Two different coatings were selected
because of their opposite impact on particle circulation
in the blood. While PEG coating is known to enhance
circulation time, amphiphilic polymers are negatively
charged and are expected to bemore rapidly captured
by livermacrophages. NHswere stable inwater regard-
less of the coating and had hydrodynamic diameters of
about 60 nm. Polymer-coated NHs were stable in 0.9%
NaCl and in PBS, while PEG-coated particles tended to
aggregate in 0.9% NaCl in 1 h and more slowly in PBS
(Supporting Information Figure S3). Both PEG-coated
and polymer-coated NHs tended to aggregate in Dul-
becco's Modified Eagle's Medium (DMEM) free of fetal
bovine serum (FBS), but they were both stable over
48 h in DMEM with either 10% or 50% FBS, with
hydrodynamic diameters of 140 and 117 nm in 10%
FBS and 91 and 62 nm in 50% FBS, respectively
(Supporting Information Figures S4 and S5). Impor-
tantly, gel electrophoresis and TEM of particles that
were magnetically separated from the full media
(0, 10% and 50% FBS) demonstrate the presence of
proteins at the surface of NPs for both types of coating
(Supporting Information Figures S6 and S7). Therefore,
we can conclude that both types of particles interact
with proteins when FBS is present in the medium and
the protein adsorption (the so-called protein corona)
has a stabilizing effect on small NH agglomerates. The
fact that PEG-coated NHs are less stable in saline
solution and unexpectedly interact with proteins may
be due to the presence of exposed gold surface: gallic
acid has lower affinity toward gold, while in contrast,
the gallol group represents a strong ligand moiety for
iron oxide surface. On the other hand, the amphiphilic
polymer can wrap around the entire NH both the gold
and the iron oxide domains. In support of this point,
by thermogravimetric analysis (TGA), a weight loss
of about 9% was measured on PEG-coated NH against
a higher loss of 23% for the PC-NH (see Support-
ing Information Figure S8). This corresponds to ap-
proximately 157 PEG molecules (molecular weight of
3125 g/mol) per NH and 61 of much longer polymer
(30000 g/mol) for the PC-NH. Given the difference in
ligand number and the factor of 10 on their molecular
weight, there is likely a higher surface coverage of the
amphiphilic polymer on NHs than PEG.
In addition, it is likely that different types of proteins
might adsorb on the particles depending on the ligand
charge (amphiphilic polymer provides amore negative
surface to the NH than the neutral PEG) and also on
the percentage of serum used in the experiment.43
Importantly, both types of particles were injected
intravenously in a saline suspension immediately after
dilution (within 1 h, the particles show similar stability
in 0.9%NaCl solution). Gold and iron content in PC- and
PEG-coated NHs are summarized in Table 1.
Degradation of NHs in Acidic Medium. In vitro experi-
ments allow monitoring of the morphological trans-
formations of single NHs in a medium mimicking
intracellular lysosomal environment. Particles were
immersed in an acidic citrate medium (pH 4.7, 20 mM
citrate).44 Of note, thismediumdoes not fully represent
lysosomes, which have different types of enzymes and
small molecules in these organelles, but this media will
allow us to determine two important parameters (pH
and iron chelators) on the transformation of the NHs.
Water-suspended polymer-coated NHs were deposited
Figure 1. Representative TEM micrographs of the polymer-coated gold/iron heterostructures. (A and B) HRTEM micrograph
showing the cube-on-cube epitaxy of gold and iron oxide structures oriented along the [001] zone axis. The FFT in inset 1 was
calculated on the iron oxide structure (area 1) and it is indexedwith the inverse spinel structure of iron oxide. The FFT in inset
2 was calculated on the superposed iron oxide/gold structures (area 2) and it is indexed with the FCC structure of gold. Gold
particles are also distinguished by their higher TEM contrast. (CF) TEMmonitoring of single polymer-coated NHs immersed
in the acidicmedium for different time-points, 0 h (C), 1 h (D), 3 h (E), and 4h (F).Weobserve the progressivedissolution of iron
oxide moieties, leaving resilient gold particles. Note that the dissolution is not homogeneous among NHs. (GI) HRTEM of a
single NH degradation after 0, 30, and 60min in the lysosome likemedium. Iron oxide crystals are organized as petals around
the resilient gold core and are eroded with distinctive kinetics.
TABLE 1. Elemental Analysis of the Nanoheterostructures Samples Used in the Study
stock concentration injected dose
Fe Au Fe Au
g/L g/L Fe/Au Ratio μmol/kg μg μmol/kg μg
PC-NHs (polymer-coated) 6.38 1.99 3.2 50 56 4.4 17.5
PC- hollow NHs 5.86 0.6 9.8 not injected
PEG-NHs (PEG-coaed) 4.18 0.89 4.7 50 56 3.05 12
on a lacey-carbon-film-coated copper TEM grid, and
their initial morphology was observed. The grid was
subsequently immersed in the acidic citrate medium,
and the same nanoparticles were observed repeatedly
at different time-points. As shown in Figure 1CF, the
gradual dissolution of iron oxide nanocrystals around
unaffected gold cores was observed in a few hours.
Such dissolution was not observed in water and phy-
siological medium. As previously described for iron
oxide nanocubes,32 the dissolution rate is uneven
among nanocomposites: some of them are left intact
after 4 h of exposure in the acidic citrate medium,
whereas others lost their iron oxide component after 1
and 3 h. Such behavior can be related to the hetero-
geneity of polymer coverage, which raises a first shield
to the access of citrate to the crystal and delays iron
oxide dissolution (Supporting Information Figure S9).
Importantly, the distinct behavior of gold and iron
oxide observed at the nanoscale illustrates the differ-
ent reactivity of these materials to acidic citrate medi-
um, which favors iron oxide dissolution. Note that the
persistent gold seeds pinpoint the initial location of
heterostructures and reveal the progressive erosion
of iron oxide. The presence of degraded iron oxide
crystals around the gold “tracers” rules out the possi-
bility of the detachments of the iron oxide component
in the NHs. Furthermore, atomic scale imaging, exem-
plified in Figure 1GI, shows that iron oxide conserves
its atomic structure after the degradation and that iron
oxide/gold interface remains intact. The figure also
reveals the lobulated structure of iron oxide around
the gold particle. Each lobe or petal (1 to 3 per NH)
having its proper crystalline orientation also degrades
independently with its own kinetics. Similar behavior
was observed for the PC- (Figure 1) and PEG-coated
NHs (Supporting Information Figure S10), although the
iron oxide degradation seemed faster for the PEG-NHs.
To investigate if the heterostructure of the particles
could play a role on iron oxide degradation, the gold
moieties of polymer-coated NHs were dissolved by
selective etching of the gold domain using the iodine
tincture (Supporting Information Figure S11).45 Inter-
estingly the lobulated structure of iron oxide was still
observed after gold removal. Iron oxide dissolution in
the acidic medium opened a gap between each lobe
and tended to separate them (Supporting Information
Figure 2. ESRmonitoringof superparamagnetic iron fromNHs in acidic citratemedium. Superparamagnetic heterostructures
show a characteristic ESR spectrum displayed in (A) for PEG-NHs at different time-points in degradation medium (Initial
spectrum of PC-NHs is similar). The measurement of ESR absorption signal provides a specific quantification of super-
paramagnetic iron (SP iron) represented in (B) as a function of time in degradation medium. Solid lines represent
monoexponential fit with a characteristic decay time. Dissolution is faster for PEG-coated NHs (PEG-NHs, decay time of
24 days) in comparison to the polymer-coated hollow (PC-hollow NHs, 108 days) and full NHs (PC-NHs, 63 days). Upon time in
degradationmedium, we observe a shift of the resonance field toward higher fields (C) and a diminution of the line width (D),
which are consistent with the diminution of magnetic volume of the NHs over time. These evolutions are less pronounced for
PC-NHs and PC-hollow NHs in comparison to the fast degrading PEG-NHs.
Figure S11). Since the amphiphilic polymer was not
affected by the iodine treatment, it might have filled
the cavity left by gold dissolution, thus protecting the
particles from internal degradation. From HRTEM
(Supporting Information Figure S12), we found that
the dissolution mainly occurred at the interface of the
iron oxide “petals”, but that some cavities also became
larger due to the degradation of the iron oxide, which
suggests the uneven distribution of polymer in the
cavity after gold removal. Overall, in situ observations
of NHs degradation confirm the protective roles of
polymer and of the gold/iron oxide interface on de-
gradation, shielding the iron oxide from citrate iron
chelators.32,33
Properties of NHs during Transformation. We next eval-
uated the evolution of magnetic and optical properties
of NHs when dispersed in the acidic citrate medium at
a fixed concentration (10 mM of iron). Electron Spin
Resonance (ESR) was used to quantify the amount of
iron that contributes to the superparamagnetic prop-
erties of the particles (denoted here as superparamag-
netic iron).16 Original NHs in water suspension display
a characteristic ESR spectrum whose total absorp-
tion signal is proportional to superparamagnetic iron
(Figure 2A). In contrast, free iron ions that can be
released from the particles have no ESR signal at
room temperature. In acidic citrate medium, the ESR
absorption of NHs decreased in intensity reflecting the
loss of superparamagnetic iron over time (Figure 2A,B).
Concomitantly ESR resonance field increases while the
line width decreases indicating a diminution of mag-
netic size (Figure 2C,D).46 Importantly, as previously
observed for iron oxide nanocubes,32 PEG-NHs de-
grade much faster than their amphiphilic polymer-
coated counterparts. In contrast, removal of the gold
core on PC-coated particles does not accelerate the
degradation of iron oxide, suggesting a redistribution
of the polymer shield. In line with ESR quantification,
we observe a drastic decrease of the field-dependent
magnetization of PEG-NHs within a few weeks in the
acidic medium (Figure 3A). The temperature depen-
dence of the magnetization also indicates some
changes in magnetic behavior: the blocking tempera-
ture corresponding to maximum magnetization (i.e.,
the temperature of transition between rigid dipole and
superparamagnetic behavior) is shifted toward lower
temperatures indicating a decrease of Néel relaxation
time, which is consistent with a diminution of the
magnetic size over time (Figure 3B). Hence, not only
the magnetization of the particles decreases, but also
their magnetic dynamics is modified by the transfor-
mation of the NHs in the acidic medium. Likewise, the
optical extinction spectrum shows that the absorbance
decreases below 500 nm due to the degradation of iron
Figure 3. Evolution of themagnetic and optical properties of PEG-coated NHs dispersed in acidic medium. (A) Magnetization
as a function of the magnetic field applied. Note the decrease of initial magnetic susceptibility with time in the lysosome-like
medium. (B)Magnetization as a functionof temperature for zero-field-cooled suspensionofNHs. Themagneticfield applied is
50 Oe. Again the magnetization is decreased upon time, and the blocking temperature of the particles (temperature of
maximum magnetization) is shifted toward lower temperatures with time. This shift indicates a reduction of the Néel
relaxation time or anisotropy energy of the particles. Overall, themagnetic size of the particles is reduced upon degradation.
(C) Absorbance of NHs is diminishing with time in the acidic citrate medium. Low wavelength extinction due to iron oxide is
decreasing, while the plasmon resonance peak of gold particles (see the inset) becomes increasingly more visible with time.
Note that the peak (around 540 nm) is slightly red-shifted in comparison to that of 5 nm gold particles (520 nm) due to the
local dielectric environment.
oxide nanocrystals, making the plasmon resonance peak
of the 5 nm gold particles more apparent (Figure 3C).
Hence, the evolution of magnetic and optical proper-
ties is in agreement with the observed dissolution of
iron oxide around the resilient gold nanocores. It must
be noted that the kinetics of dissolution is much faster
on TEM grids than in solution, as already reported for
nanocubes.32 In line with these results, the dissolution
of iron oxide nanospheres was shown to depend on
the ratio of citrate ions per particle in suspension.16
In Vivo Transformation. Prior administrations to ani-
mals the particles were dispersed ex tempore in phy-
siological saline. The suspension was well dispersed
and was easily administered through an insulin sy-
ringe. The administration to the animals of each group
took less than 10 min, when both, PEG-coated and PC-
coated NHs were equally stable. Mice were intrave-
nously injected with the nominal dose of iron oxide
used in clinical practice and preclinical assays for MRI
studies (50 μmol of iron/kg). For a 20 gweighedmouse,
the injected dose is 56 μg of iron and 14 μg of gold for
PC-NHs (12.7 μgof gold for the PEG-NHs). Notably, gold
administration associated with NHs is low in compar-
ison to previous studies investigating the distribution
of gold nanoparticles.23 However, despite the low dose
of gold, we were able to track nanoscopic transforma-
tions of nanoparticles within the principal organs of
accumulation, namely, the spleen and the liver, up to
one year after particles administration. Regardless of
the time points after injection and the nature of
particle coating, the particles were always found with-
in intracellular vesicles, presumably lysosomes, into
macrophage-like cells (Kupffer cells in liver and macro-
phages or Ito cells in spleen) adjacent to hepatocytes
(easily recognizable by their regularly circular nucleus
and abundant mitochondria and glycogen) (see Sup-
porting Information Figure S13). At day 1 after admin-
istration (Figure 4), the hybrid structure of the particles
was intact as observed on bright field TEM and high
angle annular dark field (HAADF) scanning transmis-
sion electron microscopy (STEM) images. Atomic scale
resolution can be achieved on single NHs in organs by
imaging ultrafine slices of 30 nm in thickness. The
intact NHs with both PEG-coating (Supporting Infor-
mation Figure S13) and PC-coating (Figures 4 and 5A)
werewell dispersed in the lysosomes despite their high
local concentration. In addition, the iron-rich ferritin
proteins coexisted in proximity to NHs (red arrows in
Figure 4 and Supporting Information Figure S13).
From day 7 and up to 12 months after injection of
PC-coated NHs, we still observed intact heterostruc-
tures, but also highly electron dense small particles,
often forming strings or chains (Figure 5B,C and Sup-
porting Information Figure S14). By analyzing these
structures with HRTEM and STEM-EDX nanoanalysis,
we identified gold particles with residual iron oxide
Figure 4. Multiscale TEM tracking of polymer-coated heterostructures in spleen and liver at day 1 postinjection. NHs are
confinedwithin intracellular lysosomes ofmacrophages in liver and spleen. (A) Livermacrophage (= Kupffer cell, N denotes its
nucleus) between two hepatocytes (HC). The square indicates the NH-containing lysosome. (B) Higher magnification of
electron dense NHs coexisting with less dense iron-rich ferritin proteins (red arrows). (C) High-resolution TEM reveals the
intact hybrid structure of particles with highly electron dense gold core and medium electron dense iron oxide petals.
(D) Splenic macrophages (N, nucleus; black square, NH-loaded lysosome). (E) Magnified view of the square on (D). (F) High
angle annular dark field (HAADF) scanning transmission electron microscopy (STEM) micrograph of intralysosomal NHs
showing the bright gold particles colocalizing with less intense iron oxide nanocrystals.
(Figure 6). The presence of iron oxide traces onto gold
particles unambiguously confirms iron oxide local dis-
solution in vivo (Supporting Information Figure S15).
Remarkably, the remnant gold particles play the role of
long-lived tracers to highlight the local (and some-
times complete) degradation of iron oxide nanocryst-
als. Resilient gold particles becomemore frequent over
time, both in liver and in spleen, and they surprisingly
assemble into longer chains, lattices or clusters
(Figure 5BE day 7 to day 90 in spleen, Figure 7AC
day 90 in spleen, Supporting Information Figures S16
day 90 in liver, Supporting Information Figure S17 day
360 in spleen). Even more compelling, 30 days post-
injection the diameters of gold cores diminished to
23 nm, in comparison to their initial 5 nm diameter in
heterostructures. Eroded seeds were unambiguously
Figure 5. Ultrastructural data of the spleen: (A) Spleen section at D1 when NHs, localized in splenic lysosomes, do not exhibit
any particular alterations (with gradual magnifications of the zone in the square). (B) At D7, gold core residues start forming
characteristic chains, which coexist with unaltered heterostructures. (C) At D14, some particles start forming complex
assemblies made of smaller gold residues (red arrow), zone magnified on the right side. (D) Spleen at D30 and (E) Spleen at
D90 where distinctive chains and assemblies of gold residues are manifested together with unaltered heterostructures.
identified as gold particles by STEM-EDX (Figure 7BE).
The finding that gold particles undergo progressive
degradation inflicted by the local environment is very
significant, as the toxicity/translocation/excretion pro-
files of gold nanoparticles have been related to their
size.23 It is worth noticing thatmacrophages are known
to produce hydroxyl radicals, which are able to etch
noble metal nanoparticles.47
We postulate that the biotransformation of NHs
occurs in two stages: first stage is the dissolution of
iron oxide crystals that takes place around persistent
gold particles (Figure 6) and second stage is the
degradation of gold particles to form progressively
smaller particles (Figure 7) that tend to self-assemble.
Importantly, the lysosomemedium induces uneven
dissolution of particles and some NHs resist to degra-
dation over one year after particle administration
(Supporting Information Figure S17). The finding is in
line with the step-by-step observation of NHs in acidic
citrate medium showing that each heterostructure has
its own kinetics of degradation. Similarly, iron oxide
nanocubes could display intact shapes following few
months after administration to mice, while most cubes
have been degraded and lost their magnetic prop-
erties.32 What protects some particles from dissolution
and conversely triggers the degradation of others
in vivo is still unclear. We previously reported that the
dissolution of iron oxide nanocubes started at loca-
tions where the polymer coating was missing or was
less dense (typically at cube edges).32 The situation
in vivo is more complex since NHs interact first with
plasma proteins52,53 and then with cellular and lyso-
somal constituents during cell uptake and process-
ing.48,49 How does the biological corona influence the
nanocrystal degradation within the proteolytic envi-
ronment of lysosomes is currently unknown. The ag-
glomeration state and local density of nanoparticles in
lysosomes also evolve over time: typically, NHs are
confined at relatively high density at short times after
injection, whereas they tend to individualize on the
lysosome margins or to segregate into some electron
dense areas of the lysosomes at longer time-points
(see for instance Supporting Information Figures S13
and S16). Cellular metabolism for detoxification of
endogenous and xenobiotic hydrophobic compounds
may be involved in the redistribution and degradation
of the coated heterostructures and of the gold rem-
nants. The presence (or de novo synthesis) of ferritins,
the iron storage proteins that are observed in proximity
of nanoparticles, suggests their involvement in the
degradation mechanisms by incorporating free iron
ions that are released from iron oxide crystals.
Another striking point is the spontaneous forma-
tion of chains and the assembly of resilient and de-
graded gold particles. While most NHs are well sep-
arated on day one postinjection due to their polymer
shell and/or protein corona, they tend to form chaplets
at longer time-points, suggesting that the polymer/
protein shell has been degraded or has detached in
lysosomes. The small residual gold particles, which
Figure 6. Two-stage element-specific biodegradation of NHs: first stage, dissolution of iron oxide around resilient gold core
observed on D14 in spleen. (A) Dark field (STEM-HAADF) micrograph of a splenic lysosome reveals intact NHs close to chain-
forming bright residues (red square). (B) Magnification of the red square in (A). (C) STEM-EDX nanoanalysis on line 1 and 2 in
(B). Iron and gold intensity profiles in line 1 and line 2 reveal partial or total disappearance of iron oxide surrounding the gold
core. (D) High-resolution TEM also confirms that some gold particles still have interfaces with iron oxide while others consist
of pure gold monocrystals.
ensued from the degradation of 5 nm gold cores also
tend to form dynamic superstructures as exemplified in
Figure 7. Importantly, neither chain formation nor gold
particles degradation and assembly were observed
in vitro in acidic citrate medium. This suggests that
biological effectors of the lysosomes (responsible for
enzymatic and redox activities, for instance) are involved
in nanoparticles processing, including individual trans-
formations aswell as recurrent reorganization. Of course,
further work is needed to decipher the nanobiointerac-
tions occurring in lysosomes over the time of nanopar-
ticles persistence within the body. Interestingly, in a
recent study, gold particles were organized with DNA
to form superstructures that degrade inmacrophages to
escape from the body by renal clearance.50 Thus far, our
study provides direct in vivo evidence of iron oxide
dissolution and transformations of gold particles.
Evidence for Elimination of NHs and Role of Surface Coating.
The two constitutive materials of heterostructures, iron
oxide and gold, were monitored simultaneously up
to one year postinjection in liver, spleen, kidney, and
lung by inductively coupled plasma-mass spectrometry
(ICP-MS) and ESR, respectively (Figure 8). While ICP
elemental analysis remains the “gold standard” for the
quantification of gold in tissues, iron quantification by
elemental analysis is inaccurate as the endogenous iron
exceeds the quantities of iron administeredwithin nano-
particles (56 μg). In contrast, ESR specifically measures
superparamagnetic nanoparticles (with a detection limit
of 10 ng of iron) but not diamagnetic or paramagnetic
iron due to endogenous iron species or nanoparticles
byproducts.17,51 Hence, the evolution of ESR signal in
organs directly reflects the loss of superparamagnetic
iron due to degradation or clearance of NHs.
Figure 7. Two-stage element-specific biodegradation of NHs: second stage, degradation of gold particles and formation of
gold residues assemblies observed on D90 in spleen. (A and B) Bright field TEMmicrographs showing residual intact NHs and
degraded NHs assembling together. (C) STEM-HAADF micrograph of (B) showing different contrast of gold residues (blue
window) and iron-rich ferritin proteins (red window). (D) STEM-EDX nanoanalysis of the blue window in (C) identifies the
electron-dense residues as gold particles characterized by AuLa and AuLb peaks. (E) The size distribution of initial gold cores
(mean diameter of 5.01( 0.86 nmat day 1 in vivo) is shifted to lower sizes (mean diameter of 3.05( 0.64 nm) after dissolution
of iron oxide at day 90, revealing the gradual erosion of gold particles.
As expected from previous studies on monocom-
posite gold or iron oxide nanoparticles and from TEM
observations,17,23,31 the major uptake of NHs occurred
in liver and spleen. The gold content in kidneys and
lungs in treated animals was comparable to control
animals, irrespective of the time points after injection.
Superparamagnetic iron was not detected in lungs,
confirming the good dispersion of the injected NHs,
which were not blocked in lung capillaries at short
times post injection. Magnetic iron oxide was detected
in kidneys at a very low dose (<0.04% injected dose)
and slightly decreased with time (Supporting Informa-
tion Figure S18), which is consistent with a transient
and continuous passage through the kidneys, prior the
excretion into the urine. We never observed any
pathological histological alterations in these organs
(Supporting Information Figure S19). Interestingly, the
accumulation in liver increased 2-fold when polymer
coating was used in comparison to PEG attainingmore
than 80% of the injected dose of iron oxide at day 1
postadministration (42 versus 19 μg/g of magnetic iron
in liver for PC-NHs and PEG-NHs, respectively, 51 versus
43 μg/g in spleen) (Figure 8). This is consistent with the
camouflaging role of PEG to decrease opsonization
and increase the circulation time of nanoparticles.5254
In contrast, the negatively charged amphiphilic poly-
mer is not as efficient to avoid macrophage uptake in
liver and spleen.
When looking at the evolution of the quantities of
magnetic iron oxide over time, we observe a progres-
sive decrease in concentration in the liver and spleen,
which is faster for PEG-NHs in comparison to PC-NHs,
and slower in spleen than in liver. Worthy of note is the
almost total disappearance of magnetic iron from liver
when PEG coating is used. In contrast, one year post-
injection, more than 10% of the injected dose of
PC-coated iron oxide still persists in the liver and 2%
in the spleen (corresponding to one-third of the parti-
cles concentration at day 1, i.e., 12.4 μg/g of magnetic
iron). Since degradation of iron oxide was unambigu-
ously observed in the spleen and the liver thanks to the
gold tracers, we can confirm that the elimination of
magnetic iron from these organs is at least partially due
to local transformation and dissolution, rather than the
excretion of intact particles from the organ. This is
important since the organ (and especially the macro-
phages) must locally process the nanoparticles and
manage free iron ions that are released from the
particles. One hypothesis is the local transfer of re-
leased iron into proximal ferritin proteins, as suggested
by TEM observations.
Strikingly, the longer persistence of PC-coated NHs
in comparison to PEG-coated counterparts might be
the results of the lower degradability rate, as first
observed in the acidic citrate medium, suggesting a
long-lasting role of the polymer-shell (and associated
protein corona) in the protection of the iron oxide
crystals in vivo. In contrast, PEG coating offers a more
vulnerable shell that may speed up the in situ crystal
degradation. The coating also affects the initial NHs
concentration in the liver and the spleen, which may
in turn influence nanoparticle degradation rate. As we
Figure 8. Quantification of superparamagnetic iron (SP iron)measured by ESR and of goldmeasured by ICP-MS in spleen and
liver as a function of time after single administration. SP iron and gold content are expressed as percentage of the injected
dose. Bars are standard error of the mean for 4 to 5 mice at each time-point (except at day 360, only 1 mouse for PC-NHs,
nonmeasured (NM) for PEG-NHs) (*: P<0.05, **: P<0.01, ***: P< 0.001, black stars are related to Student t test comparing each
time-point to D1 for the same coating and red stars comparing PEG-coated and polymer-coated NHs for each time-point).
observed previously for iron oxide NPs injected at
different doses,17 the liver may have a limited capacity
to handle iron oxide degradation thus longer time-
frames are required to manage larger fractions of
sequestered nanoparticles. The local overload of iron
oxide in macrophages may induce a saturation of the
homeostatic capacity of the iron-regulating system.
In line with previous studies investigating the fate
of gold particles,23 gold originating from NHs mainly
accumulated in liver and spleen (4.9 versus 1.6 μg/g of
gold in liver for PC-NHs and PEG-NHs, respectively,
22 versus 10 μg/g in spleen at day 1) (Figure 8). Con-
sistent with the proportions of iron oxide, gold uptake
in these organs was about two times larger when PC-
NHs were injected in comparison to PEG-NHs, confirm-
ing the impact of primary particle shell.53 However, by
comparing the ratio ofmagnetic iron over gold content
(reported to their respective injected dose) (Sup-
porting Information Figure S20), we observe an excess
of magnetic iron in the liver at day 1 and reversely an
excess of gold in the spleen. This suggests that a
fraction of NHs is able to fragment to individual gold
or iron oxide subunits at early time-points (occurring
prior to day 1 after injection) and that the separated
subunits have distinct distribution paths due to differ-
ent sizes or composition. Interestingly, such element-
specific biodistribution has been observed recently for
goldsilver nanoshells.55
Considering the clearance kinetics, the gold con-
centration in liver and spleen decreases only slightly in
comparison to magnetic iron oxide, the latter decreas-
ing by a factor of 2-fold one year following the admin-
istration. This illustrates the long-term persistence of
gold nanoseeds, and this finding is in linewith previous
investigations showing slow and size dependent elim-
ination of PEG-coated gold particles from these
organs.56 The kinetics of gold retention coming from
NHs is comparablewith a previous report on 4 nmPEG-
coated gold particles which peaks at 7 days postinjec-
tion and decreases faster than for larger particles.56
Remarkably, our TEMobservations of the erosion of the
5 nm gold cores showing their disintegration into
smaller particles can account for their long-term elim-
ination if we assume that very small gold particles or
molecular gold can be excreted from the liver through
hepatobiliary clearance. It has been shown before that
small gold NPs of 10 nm showed the most widespread
organ distribution in comparison to larger particles,25
suggesting possible translocation between organs.
Semmler-Behnke et al. also reported that the transloca-
tion of gold NPs from lungs to secondary target organs
was inversely proportional to the NP diameter28,57 and
that the hepato-biliary clearance from liver at 24 h
postinjection strongly increased for 2.8 nm size and
below.58 Here, the intralysosomal degradation of gold
cores, once iron oxide has been first dissolved, can
facilitate the long-term secondary excretion of ultra-
small gold residues from the liver and, to a lesser
extent, from the spleen. Conversely, the formation of
large assemblies of gold particles within lysosomes
may also explain the one-year persistence of gold in
these organs. Hence, we clearly observe a material-
dependent elimination process, which is related to the
different reactivity of gold and iron oxide to the local
environment, and is probably also connected to dif-
ferent biological requirements to degrade/reuse/
eliminate the constituents of these two materials.
CONCLUSION
This study investigates the one year fate of gold/iron
oxide nanoheterostructures after intravenous admin-
istration to mice. Gold and iron oxide portions of
the NHs reveal distinct distribution and elimination
kinetics. Heterostructures are degraded following a
two-stage process including the primary dissolution
of iron oxide crystal around the resilient gold core and
the secondary degradation of 5 nm gold particles into
smaller particles that self-organize into chains or
assemblies. In situ degradation of gold particles within
hepatic and splenic lysosomes can explain the slow
elimination of gold from liver and spleen due to
translocation and/or excretion mechanisms, which
can be set on by the reduced size of gold crystals. On
the contrary, large assemblies of gold particles may
account for their long-term persistence up to one year
postinjection.
The comparison of two different NHs coatings,
amphiphilic polymer or PEG shell, indicates that the
synthetic surface identity has long lasting impact on
the history of nanoparticles in the body. Our results on
hybrid nanoparticles, combining materials with differ-
ent reactivities, suggest new directions in the control
of the degradation, biodistribution, and clearance of
multifunctional nanomedicines.
MATERIALS AND METHODS
Synthesis, Coating, and Characterization of Gold/Iron Oxide NHs. The
synthesis method chosen for the production of heterostruc-
tures is based on a previously reported protocol by Sun.35 Oleic
acid (1.9 mL, 90% purity), oleylamine (2 mL, 70%), 1,2-hexade-
canediol (2.58 g, 90%) and 1-octadecene (20 mL, 90%) were
placed in a 100 mL three-neck flask, heated up at 100 C, and
kept under vacuum for 45min. The temperaturewas then raised
at 120 C and 300 μL of iron pentacarbonyl (99.99% kept in
glovebox) was injected. Three minutes later, a mixture of 50 mg
of gold(III) chloride trihydrate (99.9%, stored under nitrogen) in
0.5 mL of oleylamine and 5 mL of octadecene, was added and
the temperature was raised from 120 to 310 C in 10 min and
kept at 310 C for 90 min. After the reaction pot had cooled
down, three washing steps were performed by addition of
2-propanol and centrifugation, followed by redispersion of
the precipitated heterodimers in hexane. At the last washing
step, the sample was dissolved in 15 mL of chloroform, and
50 μL of oleylamine was also added.
Water Transfer by Polymer Coating Procedure. The as-
synthesized batch of heterodimers was transferred from chlo-
roform to water using a polymer coating protocol well-
established in our group.39 A total of 16 mL of poly(maleic
anhydride-alt-1-octadecene) (137 mM in chloroform) was added
to 60 mL of nanoparticles solution (0.2 μM in chloroform). This
corresponds to approximately 500monomer units per nm2. The
nanoparticle concentration was calculated by measuring the
gold by elemental analysis, while the total surface area was
approximated to a spherical object having an overall diameter
given by the sum of the gold and the iron oxide diameters.
The solvent was evaporated slowly using a rotary evaporator (at
400mbar and 40 C for 2 h). Then, 3.7mL of bis(hexamethylene)
triamine (20 mM in chloroform) was added corresponding to
10 cross-linker molecules per nm2. The solution was sonicated
for 10 min at 40 C. Subsequently, the solvent was removed
under reduced pressure (a first step at 400 mbar and 40 C for
2 h, then a second step at 200 mbar at 40 C for 1 h, and a last
step at 100 mbar and 40 C for 30 min until all the solvent is
evaporated). Five milliliters of aqueous sodium borate buffer
(50 mM, pH 9) was added, and the mixture was sonicated at
65 C for 2 h. The solution was stored overnight at 65 C under
shaking, and later concentrated to a volume of only 12 mL by
centrifugation filtration with a centricon tube (15 mL, MWCO
100 kDa) at about 1700 RCF. The polymer coated nanoparticles
were cleaned from the excess of polymer by ultracentifugation
performed by depositing 1 mL of sample on a discontinuous
sucrose gradient (2mL/10%, 3mL/40%, 4mL/60%) and running
the centrifugation at about 15 000 RCF for 1 h.When using these
conditions, the heterodimers sample was placed in the middle
part of the gradient while the excess of polymer was stuck on
the top of the gradient. The sucrose gradient containing the
heterodimers was recovered from the gradient, concentrated,
and cleaned from the sucrose on centricone tubes.
Etching Procedure for the Fabrication of Empty Heterostruc-
tures. To prepare empty NHs, we have selectively etched the
gold nanocrystals from the polymer-coated gold/iron oxide
heterostructures, by adjusting a protocol previously developed
by us to obtain empty heterostructure directly in organic
solution.45 To 4 mL of polymer coated gold/iron oxide NHs
(0.2 μM in water) was added 8mL of iodine solution (Tincture of
iodine 7% in p/v of iodine and 5%of potassium iodide inwater and
ethanol). After a 24 h reaction at 50 C under vigorously shaking,
the sample was centrifuged on centrifuge filters (MW 100 kDa) to
remove the excess of iodine compounds and gold ions. Under
these conditions, together with the hollow NHs also a fraction of
the initial gold/iron oxide heterostructures was still present. To
separate the hollow NHs fraction from the full one, a purification
was performed on a discontinuous sucrose gradient (4 mL of 50%
sucrose, 3 mL of 50% sucrose solution and 1 mL of 5% sucrose
solution and a loading sample volume of 0.5mL) at low centrifuga-
tion speed and at 4 (4000 rpm, for 210min). This allowed isolating
the hollow NHs in the middle of the gradient from the full NHs
precipitated at the bottom of the tube. The recovered sample was
finally washed by centrifugation to remove the sucrose.
Water Transfer by PEG Ligand Exchange Procedure. Alterna-
tively, to transfer the surfactant coated gold/iron oxide NHs into
water, a ligand exchange procedure was employed by choosing
the gallic functionalized polyethylene glycol (Gallol-PEGOH)
as the ligand exchange molecules.41 To 10 mL of the ligand
Gallol-PEGOH solution (0.05 M in CHCl3) and 1 mL of triethyl-
amine was added 5 mL of stock solution of NHs such that the
final NH concentration was set at 1 g/L of Fe in the CHCl3 phase.
The mixture was then diluted with 50 mL of toluene, shaken,
and transferred in a separating funnel. Then, 250 mL of de-
ionizedwater were added, resulting in a two-phasemixture that
was gently shaken. After the ligand-exchange took placed, the
heterostructures were laid at the toluenewater interface. After
emulsification bymeans of shaking, the phases were allowed to
separate and the aqueous phase containing NHs bearing gallol-
PEGOH was collected. This step was repeated until all
NHs were transferred into water and the organic phase was
completely transparent. The total water volume was brought to
10 mL under reduced pressure at 40 C (300 mbar for 30 min,
200mbar for 30min, 77mbar for 30min and 10mbar for 10min)
and the excess of Gallol-PEGOH was removed by dialysis
(membrane molecular cutoff of 50 kDa) in a deionized water
bath. The sample was left in dialysis under stirring for 2 days at
room temperature. Finally, the NHs solution was concentrated
by centrifugation in a centrifuge filter (molecular cutoff point
100 kDa), and the recovered solution of PEG-coated NHs was
analyzed by DLS and TEM.
In Vitro Degradation Study. To mimic the lysosomal medium,
NHs were dispersed in a citrate buffer at pH 4.7 at a concentra-
tion of 10 mM in iron. The citrate buffer was prepared bymixing
4.4 mM of citric acid (C6H8O7, Fluka, >99.5%) and 5.6 mM of
sodium citrate tribasic (C6H5Na3O7 3 2H2O, Fluka,>99%) in
500 mL of purified water.
In Vivo Study. The experiments were performed in agreement
with institutional animal use and care regulation of the Paris
Cardiovascular Research Center animal facility (University Paris
Descartes). The animals were allowed to acclimate to this facility
for at least 1week beforebeing used in the experiments andwere
fed a standard diet ad libitum throughout the experiments.
Pathogen-free female 8 week old C57/Bl6 mice (mean weight
20.5( 1g) (Janvier, France)) were injected in the retro-orbital vein
with PC-NHs or PEG-NHs suspended in 100 μL of physiological
saline medium at a dose of 50 μmol iron/kg (injected dose of
56 μg iron). Four mice injected with PC-NHs, four mice injected
with PEG-NHs, and five control noninjected mice were sacrificed
at each time point after NHs injection (at days D1, D7, D30, D95
and D180, respectively). One mouse injected with PC-NHs was
sacrificed at Day 360. Liver, spleen, kidneys, and lungs were
excised and prepared for TEM, histology, ESR, and ICP-MS.
Histology. After excision, pieces of liver, spleen, lung, and
kidney were fixed with pH 7.4 phosphate-buffered 10% for-
malin and processed by embedding in paraffin. Six micrometer
thick sections were evaluated after hematoxylin and eosin,
Masson's trichrome, or Pearls and Nuclear Fast Red staining.
TEM of Organs. Organs were cut into 1 mm3 pieces after
excision and fixed with 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer, postfixed with 1% osmium tetroxide contain-
ing 1.5% potassium cyanoferrate, gradually dehydrated in etha-
nol, and embedded in Epon. Thin sections (70 nm) of selected
zones were observed with Zeiss EM902 electron microscope
operated at 80 kVe (MIMA2-UR1196Génomique et Physiologie
de la Lactation, INRA, Plateau deMicroscopie Electronique 78352,
Jouy en Josas, France). Ultrathin sections (30 nm) were sectioned
for high-resolution imaging and EDX analysis.
Characterization Techniques. High-Resolution Transmission Elec-
tron Microscopy (HRTEM) and Electron Spectroscopy. HRTEM
investigations were performed with the JEOL ARM 200 F
microscope operating at 200 kV or 80 kV for ex vivo experiments.
This microscope is equipped with a CEOS aberration corrector
and a cold field emission gun. The follow-up of degradation of
individual NHs by HRTEM was performed on lacey carbon film
on which NHs were deposited, initially observed and then
immersed for different times in the lysosome-likemediumbefore
recurrent observations. The recognizable patterns of the lacey
film facilitate the step-by-step monitoring of the NHs alteration.
STEM-EDX nanoanalysis is a powerful technique that couples the
imaging and analytical performances of electron microscope. We
used this technique in spectrum imaging mode59 on ex vivo
samples: a STEM image of the area of interest was split into a 64
 64 array of pixels. The nanometric STEM probe is then positioned
over each pixel for a dwell time of 50 ms to acquire a complete
energy dispersive X-ray spectrum (multiple scans were used to
improve signal-to-noise). The resulting multidimensional datacube
encloses spectral information for eachpixel fromwhichquantitative
chemical information can be extracted. We also performed single
point EDX analyses60 with longer acquisition times (up to 60 s) to
reveal the biodistribution of small gold and iron oxide particles.
Magnetic Measurements. Magnetization measurements
were carried out on a vibrating sample magnetometer (PPMS,
Quantum Design, Inc.) on colloidal suspension of PC-NHs and
PEG-NHs in water and in lysosome-likemedium. Field-dependent
magnetization curves weremeasured at 310 K as a function of the
external magnetic field in the range between 0 and 3  104 G.
Temperature-dependent magnetization at a magnetic field of
50 G was recorded in the 5310 K temperature range for zero-
field-cooled sample.
Electron Spin Resonance (ESR). ESR was performed with a
Varian E102 EPR (Electron Paramagnetic Resonance) spectro-
meter operating at X band (9.26 GHz). The first derivative of the
power absorption dW(B)/dB was recorded as a function of the
applied field B in the range 06000 G. Themodulation field had
a frequency of 100 kHz and amplitude of 10 G. The area of the
ESR absorption curve (calculated by a double integration of the
spectrum dW(B)/dB) was proportional to the amount of non-
degraded superparamagnetic NHs in the sample. An absolute
calibration was performed using suspensions of initial PC-NHs
and PEG-NHs (2 μL sample) at different iron concentrations
quantified by ICP-MS. Quantification of NHs in lysosome-like
medium at different time-points was performed on 2 μL liquid
sample. Before ESRmeasurements, the excised pieces of organs
were first weighed and let dry for 3 days in an oven at 80 C.
The dried organ samples were weighed again and introduced
into a quartz tube. The net mass of dehydrated organs in the
quartz tube was then weighed and ESR spectra were recorded.
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Total
iron and gold content in suspension and organs was quantified
by ICP-MS.After excision, organ sampleswere conservedat80 C
until preparation for ICP-MS measurements. The organs were
mineralized in closed vial and in the presence of 4 mL of
nitric acid at 70 C for 2 h on heat bloc (DigiPREP Jr SCP
Science) and then heat in open vial at 80 C for 10 more hours.
The volume of each samplewas adjusted to 20 or 4mLwith 3%
nitric acid in distilled water and analyzed for Fe and Au content
by ICP-MS (Thermo Electron). Amultielement solution (Tune A)
was used to optimized the experimental parameter to obtain
the maximum counting rates. Data acquisition was made in
peak jump mode with three runs for each sample (20 s long,
100 sweep per run, dwell time 200 ms). The ICP-MS set up was
calibrated with a freshly prepared serial dilution of gold and
iron standard using concentration values between 1 and
100ppb for gold and from10 to1000ppb for iron.Golddetection
limits due to instrumental noisewere evaluated from theminimal
concentration at which ICP measurement is no more linear with
concentration (about 510 ppb for gold). Noninjected organs
were also measured to evaluate endogenous gold concentra-
tions, which were below detection limits.
Optical Absorbance. Extinction spectra in aqueous suspen-
sion of NHs and in lysosome-like medium were measured on a
Cary 50 UV/vis spectrometer (Varian).
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